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Supplemental materials and methods 
Generation of antibodies. Peptide specific anti-MuRF2 and anti-MuRF3 antibodies were 
generated by immunizing rabbits with MuRF2 or MuRF3 specific peptides (BioGenes 
GmbH, Germany). Shortly, single MuRF2 or MuRF3 specific peptides (sequences are 
available upon request) were used for the intramuscular immunization of two rabbits each 
using BioGenes' adjuvant immunization. The adjuvant was mixed 3:1 with either antigen. 
Standard immunization was done over 35 days followed by blood sampling and harvesting of 
serum. Affinity purification of the serum was performed against the respective peptide. 
Purified antibodies were stored in Tris-Glycine buffer (pH 7.5) containing 250 mM NaCl and 
0.02 % thimerosal. Specificity of both antibodies was confirmed by Western blot analyses 
using lysates from MuRF1, MuRF2 or MuRF3 overexpressing COS-7 cells (Figure S11) and 
lysates of soleus, extensor digitorum longus (Figure 1A), tibialis anterior, and 
gastrocnemius/plantaris (Figure S1A) from MuRF2 and MuRF3 germline deleted mice. More 
precisely, the anti-MuRF2 antibody detected overexpressed MuRF2 but not MuRF1 or 
MuRF3. Likewise, the anti-MuRF3 antibody detected overexpressed MuRF3 but not MuRF1 
or MuRF2 (Figure S11). Accordingly, no specific immunoreactive band was found in 
muscular protein lysates from MuRF2 knockout mice with the anti-MuRF2 antibody, and 
from MuRF3 knockout mice with the anti-MuRF3 antibody (Figure 1A). With these 
antibodies we confirmed muscle specific expression of MuRF2 and MuRF3 by Western blot 
analysis (Figure S12). 
 
Muscle dissection. Soleus, extensor digitorum longus, tibialis anterior, and 
gastrocnemius/plantaris were harvested from control and DKO mice, weighted and either 
snap frozen in liquid nitrogen for RNA and protein isolation or embedded in gum tragacanth 
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(Synopharm GmbH, Germany) for histological analyses. In addition, hearts were harvested 
and treated accordingly. Tibia length was measured and used for normalization of muscle 
weights. 
 
Protein purification. The FastPrep-24™ instrument (MP Biomedicals, CA, USA) was used 
to homogenise muscle tissue in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 10 % 
glycerol, 1 % Triton X-100, pH 7.5) supplemented with protease inhibitors (cOmplete; Roche 
Diagnostics GmbH, Germany) using Micro Packaging Vials with 2.8 mm Precellys ceramic 
beads (PEQLAB Biotechnology GmbH, Germany). Lysates were cleared by centrifugation at 
16.000 g for 20 min at 4° C. Protein content in the supernatant was quantitated using Pierce® 
BCA reagent (Thermo Fischer Scientific Inc., MA, USA). Proteins were stored at -80°C.  
 
For analysis of endogenous MAPKAPK2, MAPKAPK3 and p38 MAPK tissue from left 
ventricle and soleus were homogenised in 150 µl kinase lysis buffer (20 mM TRIS-acetat 
pH 7.0, 0.1 M EDTA, 1 mM EGTA, 1 mM Na3VO4, 10 mM β-glycerophosphate, 50 mM 
NaF, 5 mM sodium pyrophosphate, 1 % Triton X-100, 1 mM benzamidine, 2 µg/ml 
leupeptine, 0.1 % 2-Mercaptoethanol, 0.27 M saccharose, 0.2 mM PMSF) supplemented with 
aluminium oxide and protease inhibitors (cOmplete; Roche Diagnostics GmbH, Germany). 
Lysates were cleared by centrifugation at 15.000 g for 20 min at 4° C. Protein content in the 
supernatant was quantitated using Bradford assay. Proteins were stored at -80°C. This 
protocol was recently published [1]. 
 
Mass spectrometry of muscle proteins. The FastPrep-24™ instrument (MP Biomedicals, 
California, USA) was used to homogenise soleus muscle of control (n = 3) and DKO (n = 3) 
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mice in denaturation buffer (10 mM HEPES, 6 M urea, 2 M thiourea, 2 % SDS) using Micro 
Packaging Vials with 2.8 mm Precellys ceramic beads (PEQLAB Biotechnology GmbH, 
Germany). Lysates were cleared by centrifugation at 16.000 g for 20 min at 4° C. The 
supernatant was precipitated using ethanol precipitation. The protein pellet was resuspended 
in denaturing buffer. Disulfide bridges were reduced using 10 mM DTT followed by an 
alkylation step using 55mM chloroacetamide. Proteins were digested following a two step 
protocol, first digesting using endopeptidase LysC (Wako, 1 µg/50 µg protein), followed by a 
dilution step reducing the urea contend to 2 M urea and finally digesting the sample using 
trypsin (Promega, 1 µg/50 µg protein). Peptides were purified as described in Rappsilber et al 
2007 [2]. After elution from the stage-tip cartridges, the peptides were separated on a reverse 
phase chromatography system using nano-flow Proxeon nLC-II system, Thermo Scientific, 
in-house prepared reverse-phase-column 15 cm, 75 µm, C18, 3 µm bead size, Dr. Maisch 
HPLC GmbH). The separated peptides were ionized on a proxeon ion source. MS and 
MS/MS spectra were recorded using a Q-Exactive mass spectrometer (Thermo Scientific) 
using higher energy collision dissociation method (HCD) of the top 10 most prominent ions. 
The recorded spectra were analysed using the MaxQuant software package (version 1.2.2.5) 
using the IPI human database, with carbamidomethylation of cysteins as a fixed and oxidation 
of methionines as a variable modification. For peptides and proteins a FDR of 1 % was 
applied. 
 
Bioinformatic analysis of mass-spectrometry data. Data obtained from the MaxQuant 
analysis were used to identify significantly regulated proteins in DKO compared to control 
soleus. Proteins with a log2-fold change in abundance were considered significant if they 
were above or below the arbitrarily cut-off of 0.7 or -0.7 for up- and down-regulated proteins, 
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respectively. Three replicates were used to calculate significances using the non-parametric 
Wilcoxon-Mann-Whitney-Test. Proteins with a –log10(p-value) > 1 were considered 
significantly regulated. These significantly regulated proteins were used for the Gene 
Ontology (GO) analysis using the DAVID online tool [3]. GO-terms with a score of more 
than 3.5 were clustered using Euclidian hierarchical clustering, combining all three branches 
of the GO annotations (biological processes, cellular component and molecular functions). 
 
Affinity chromatography for quantitation of MAPKAPK2 and MAPKAPK3 in muscle. 
Enrichment of MAPKAPK2 and MAPKAPK3 was performed as previously shown [1]. 
Shortly, the GST-p38α-fusion protein and 25 µl of prewashed Glutathion-Sepharose 4B (GE 
Healthcare) were used to co-purify MAPKAPK2 and MAPKAPK3 from muscle lysates.  
Immunoprecipitation was performed in IP-buffer (25 mM TRIS-HCl, pH 7.4, 137 mM NaCl, 
2.7 mM KCl, 50 mM NaF, 1 % Triton X-100) for 12 hours at 4°C. Afterwards sepharose was 
washed 3 times with IP-buffer. To elute bound proteins sepharose was heated to 95°C for 
5 min in 20 µl of SDS sample buffer (200 mM TRIS-HCl, pH 6.8, 8 % SDS, 40 % glycerol, 
10 % 2-Mercaptoethanol, 0.08 % Bromophenol blue).  
 
Western blot analysis. Western blot analysis was performed on protein samples from 
skeletal muscles, hearts and cells, as previously described [4]. Shortly, proteins were resolved 
by SDS-PAGE and transferred onto nitrocellulose membranes (GE healthcare, Germany). 
Membranes were blocked with either 5 % skim milk powder or 5 % bovine serum albumine 
(BSA) dissolved in TBS-T for 1 hour. Following primary antibodies were used for 
immunoblotting: anti-MuRF2 (polyclonal, rabbit, 1:300, own production), anti-MuRF3 
(polyclonal, rabbit, 1:300, own production), anti-actin (monoclonal, mouse, 1:2000, Sigma-
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Aldrich Chemie GmbH, Germany), anti–β/slow MyHC (NOQ7, detecting skeletal slow 
myosin, monoclonal, mouse, 1:1000; Sigma-Aldrich Chemie GmbH, Germany), anti–pan 
MyHCII (My32, detecting skeletal fast myosin, monoclonal, mouse, 1:1000; Sigma-Aldrich 
Chemie GmbH, Germany), anti-MAPKAPK2 (polyclonal, rabbit, 1:1000, Cell Signaling 
Technology Inc., Danvers, USA), anti-p38 MAPK (polyclonal, rabbit, 1:1000, Cell Signaling 
Technology Inc., Danvers, USA), antibody. Loading was controlled with anti-GAPDH (clone 
6C5, monoclonal, mouse, 1:50.000; Millipore GmbH, Germany), anti-GAPDH (monoclonal, 
mouse, 1:1000, Biotrend Chemicals, LLC, Destin, FL, USA; for MAPKAPK analysis) and 
anti-tubulin (clone TU-02, monoclonal, mouse, 1:1000; Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA, USA) antibody. HRP-linked IgG horse anti-mouse, goat anti-rabbit (both 
1:2000, Cell Signaling Technology Inc., Danvers, USA) or rabbit anti-goat (1:5000, Abcam, 
UK) were used as secondary antibody. Proteins were visualized with a chemiluminescence 
system (SuperSignal® West Pico Chemiluminescent substrate, Thermo Fischer Scientific 
Inc., MA, USA). For the detection of MAPKAPK3, we performed p38-GST-pulldown assays 
with cell lysates followed by Western blot analysis using an anti-MAPKAPK3 antiserum as 
described previously [5]. 
 
Gene expression analyses by real-time RT-PCR. Total RNA was isolated from heart and 
skeletal muscles using TRIzol Reagent (Invitrogen™, Life Technologies Corporation, CA, 
USA) and the FastPrep-24™ instrument in accordance with manufacturer´s instructions. 1 μg 
of RNA was reverse transcribed (Superscript II Reverse Transcriptase, Invitrogen™, Life 
Technologies Corporation, CA, USA) in accordance with manufacturer´s instructions. Real-
time PCR was performed using SYBR Green (Roche Diagnostics GmbH, Germany) with 
primer sets (Table S1) and PCR conditions that have been previously reported [6]. 
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Hypoxanthine-guanine phosphoribosyltransferase (Hprt) content was used as reference gene, 
and expression of specific genes was related to stably expressed Hprt. 
 
Histological and immunohistochemical analyses. Soleus, extensor digitorum longus, 
gastrocnemius/plantaris, and tibialis anterior were harvested from control and DKO mice 
and either flash frozen in gum tragacanth (Sigma-Aldrich Chemie GmbH, Germany) or fixed 
in 4% paraformaldehyde and processed for routine paraffin histology as described previously 
[7]. Frozen sections were cut on a cryotome (Leica CM 3050 S, Leica Microsystems GmbH, 
Germany) and stained with hematoxylin and eosin, metachromatic ATPase dye or modified 
Gomori’s trichrome as previously described [7]; Gomori One-Step Trichrome with Light 
Green was purchased from Sigma-Aldrich Chemie GmbH, Germany. Frozen histological 
sections were immunostained with anti–β/slow MyHC (NOQ7, detecting skeletal slow 
myosin, monoclonal, mouse, 1:100), anti–pan MyHCII (My32, detecting skeletal fast myosin, 
monoclonal, mouse, 1:100) and anti-Laminin (polyclonal, rabbit, 1:200, all Sigma-Aldrich 
Chemie GmbH, Germany) primary antibody over night at 4°C. Goat anti-mouse and goat 
anti-rabbit IgG (Alexa Fluor 488 nm or 555 nm, 1:500, Invitrogen™ Life Technologies 
Corporation, CA, USA) were used as secondary antibody. Filamentous actin was stained with 
phalloidin-TRITC (2.5 µg/100 µl, Sigma-Aldrich Chemie GmbH, Germany). Images were 
acquired with a Leica CTR 6500 HS microscope, and Leica digital camera DFC 425 for 
histological analyses and Leica digital camera DFC 360 FX for fluorescence pictures (Leica 
Microsystems GmbH, Germany). Analyses of images were performed with ImageJ software 
1.42c (http://rsb.info.nih.gov/ij/). Myocyte cross-sectional area (MCSA) was measured from 
extensor digitorum longus from at least 100 myofibres per genotype and histological section. 
Centralized nuclei were quantitated in 60-270 myofibres per genotype and histological 
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section from both soleus and extensor digitorum longus. Fibre type composition was 
determined in 330-970 myofibres per genotype and histological section from soleus and 
extensor digitorum longus. 
 
Electron microscopy. 4-6 month old male and female control and DKO mice were 
anesthetized and systemically perfused with 4 % formaldehyde, 1.25 % glutaraldehyde in 
0.08 M phosphate buffer. Soleus and extensor digitorum longus as well as the interventricular 
septum of the heart were dissected and postfixed with 2.5 % glutaraldehyde in 0.1 M 
phosphate buffer for 3 days at 4°C. Following washing and transfer into 0.1 M cacodylate 
buffer, tissue was stained with 1 % osmium tetroxide for 2 hours, dehydrated in a graded 
ethanol series and propylene oxide and embedded in Poly/Bed 812 (Polysciences, Inc., 
Germany). Ultrathin sections (60 nm) were contrasted with uranyl acetate and lead citrate and 
examined with a FEI Morgagni electron microscope. Digital images were taken with a 
Morada CCD camera and the iTEM software (Olympus Soft Imaging Solutions GmbH, 
Germany). 
 
Measurement of muscle force. Muscle force measurements were performed as previously 
described [6]. To compare muscle function of control and DKO mice male and female 
littermates were analysed. The soleus and extensor digitorum longus were isolated and 
immediately attached to a force transducer and positioned between two steel electrodes (800A 
in vitro test apparatus, 701C High-Power, Bi-Phase Stimulator, 300C Dual-Mode Muscle 
Lever System, Aurora Scientific). The muscles were continuously perfused with oxygenated 
(95 % O2 and 5 % CO2) physiological salt solution (modified Krebs-Henseleit buffer: 
112 mM NaCl, 4.5 mM KCl, 1.2 mM MgSO4, 2.5 mM CaCl2, 1.2 mM NaH2PO4, 26 mM 
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NaHCO3, 11 mM glucose) at 25°C and pH 7.4 [8]. Muscles were allowed to equilibrate for 
15 min in the modified Krebs-Henseleit buffer. Then, the optimal length at which the muscle 
generates a maximum twitch force was determined for each muscle investigated (L0). This 
specific individual muscle length was used for all subsequent measures. Second, muscles 
were allowed to recover for 10 min. Third, soleus was stimulated with various increasing 
frequencies (2, 10, 20, 40, 60, 80, 100, 125, and 150 Hz) and force development was 
measured. The extensor digitorum longus underwent the same protocol plus an additional 
175 Hz stimulus. Resting periods of 1.5 min were applied between individual stimulation 
steps. Force development was normalised to calculated muscle cross-sectional area (CSA) as 
described by others [9]. Briefly, CSA was calculated by dividing muscle mass in mg by 
optimal length L0 in mm, the density of skeletal muscle (1.06 g/cm³) and the ratio of myofibre 
length to muscle length which is 0.45 and 0.71 for extensor digitorum longus and soleus, 
respectively [9]. Data are depicted as force-frequency curves. 
 
Isolation of adult mouse ventricular cardiomyocytes. Ventricular cardiomyocytes were 
isolated from hearts of 15-week old male DKO mice and control littermates as described 
previously [10]. All experiments followed the guidelines of the German State Department for 
Animal Protection and Welfare as well as the German Society for Experimental Animal 
Science and were in accordance with Federal German Animal Protection Law (GV-SOLAS, 
TSchG). The experimental protocol was approved by the University Committee on Use and 
Care of Animals at the Hannover Medical School and the Lower Saxony State Board on the 
Care and Use of Animals (LAVES, Oldenburg, Germany; #33.9-42502-04-11/0358). Mice 
were anesthetized with isoflurane (Baxter, Germany) using a vaporizer (E-Z-systems Corp., 
PA, USA) and anticoagulated with 500 U heparin sodium i.p. After a bilateral thoracotomy 
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the aorta thoracalis was cannulated within 30 seconds and the heart perfused on a pressure-
constant Langendorff apparatus (50 mmHg, flow: 3 ml/min) with calcium-free Krebs-
Henseleit buffer (118 mM NaCl, 4.7 mM KCl, 21 mM NaHCO3, 1.2 mM MgSO4, 11 mM 
glucose, 1.2 mM KH2PO4 and 10 mM taurine 5, 2,3-butanedione monoxime; pH 7.4) 
equilibrated with carbogen (5 % CO2, 95 % O2) at 37oC. After 4 min of perfusion enzymatic 
digestion with collagenase type II (140 U/ml, Lot M8B10274 Worthington Biochemical 
Corp., NJ, USA) and hyaluronidase type I-S (52 U/ml, Lot 029K77001, Sigma-Aldrich 
Chemie GmbH, Germany) diluted in Ca2+-free Krebs-Henseleit buffer was initiated. After 8 
min of digestion, extracellular Ca2+ was increased in two steps to a final concentration of 0.7 
mM and the perfusion continued for additional 5 min. The left ventricle was minced and 
resuspended in 5 ml of enzyme containing Krebs-Henseleit buffer. Cardiomyocyte 
dissociation was achieved by triturating the tissue (2 min, 37 oC) using sterile silanized glass 
pipettes. The resulting cell suspension was washed twice using centrifugation (30 g, 1 min) 
and resuspension in Ca2+-containing Krebs-Henseleit buffer supplemented with 2 % and 6 % 
bovine serum albumin. Finally, cardiomyocytes were resuspended in DMEM containing 0.9 
mM Ca2+ (mixture of E 15810 and E 15078: PAA-Laboratories, Austria), supplemented with 
1 % antibiotics (Penicillin/Streptomycin, Biochrom AG, Germany, 10,000 µg/ml). 
Cardiomyocytes were cultured in M199 (E15-838, PAA-Laboratories), pH 7.4, supplemented 
with 10 mM glutathione, 0.2 mg/ml BSA, 1 % antibiotic solution (Pen/Strep, Biochrom AG, 
Germany, 10,000 µg/ml) and plated onto laminin coated coverslips (40 µg/ml, Invitrogen™, 
USA). Cultures were incubated at 37oC in 5 % CO2. Only quiescent, rod-shaped myocytes 
were subjected to measurements within 10 hours. Cell size was determined by measuring 
length and width of cardiomyocytes from pictures obtained directly after the isolation 
procedure.  
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Measurements of single cell contraction and calcium transients of adult cardiomyocytes. 
Cell contractions and calcium transients were measured as described previously [10]. Briefly, 
contractile properties of cardiomyocytes in culture were measured with the IonOptix system 
(IonOptix Corporation, USA) equipped with a camera connected to an inverted microscope 
(Olympus IX71, Olympus Corporation, Japan) and sarcomere length detection software 
(IonWizard®, IonOptix Corporation, USA). A coverslip with plated cardiomyocytes was 
placed in a prefabricated chamber slowly perfused with buffer solution (117 mM NaCl, 5.7 
mM KCl, 1.2 mM NaH2PO4, 0.66 mM MgSO4, 10 mM glucose, 5 mM sodiumpyruvat, 10 
mM creatin, 20 mM HEPES, 1.25 mM CaCl2, 0.03 mM ascorbic acid, pH 7.4) at 37 oC. 
Temperature stability in the closed chamber was continuously monitored and automatically 
maintained by a temperature controller (CellMicroControls, USA). Myocytes were paced 
with 5 Hz at supramaximal voltage and 4 ms impulse duration (MyoPacer, IonOptix 
Corporation, USA). Sarcomeric contractions were recorded at 5 Hz for 30 s. The parameters 
analysed included peak sarcomere shortening as amplitude, and contraction and relaxation 
velocity after averaging 20 transients per cardiomyocyte. 
 
Ca2+-transients of cardiomyocytes were recorded simultaneously with sarcomere shortening 
using a dual excitation fluorescence photomultiplier system (IonOptix Corporation, USA) 
with 1.5 µM fura-2 AM (InvitrogenTM Corp., Molecular probes®, OR, USA) and 15 min 
loading time at 37oC. Afterwards, cells were washed twice with M199. The fluorescence 
emitted at 510 nm after alternating excitation wavelength between 340 nm and 380 nm was 
measured. Average background fluorescence obtained from 10 untreated cells was subtracted 
and the ratio (340nm/380nm) calculated as described [11]. From the ratio transients, which 
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indicate the free intracellular Ca2+-transients we analysed ratio amplitude, maximum velocity 
of Ca2+-transient increase and maximum velocity of Ca2+-transient decrease. For each 
condition 20 transients were averaged using the IonWizard® software (IonOptix Corporation, 
USA).  
 
Body composition. Body composition was measured in 5 month old male DKO (n = 4) mice 
and their control littermates (n = 8) using the LF90 II time domain NMR analyser (6.5 mHz, 
Bruker Optics, USA) [12]. Awake mice were placed into the restraint tube which was 
adjusted to minimize movements of the animal without impairing respiration. The tube 
together with the animal was placed into the LF90 II instrument, and fat mass, fat-free (equal 
to muscle) mass and fluid were measured in triplicate. 
 
Langendorff. The Langendorff heart experiments were performed as recently described [13]. 
In short, 2 month old male DKO (n = 6) mice and their control littermates (n = 4) were 
anaesthetized using 100 mg/kg ketamine and 10 mg/kg xylazin 2 %. 250 I.U. Heparin 
injected i.p. was used for anticoagulation. Hearts were excised immediately and transferred to 
a dissection dish containing ice-cold modified Krebs-Henseleit buffer (118.0 mM NaCl, 
4.7 mM KCl, 2.0 mM CaCl2, 2.1 mM MgSO4, 24.7 mM NaHCO3, 1.2 mM KH2PO4, 
0.06 mM EDTA, and 10.0 mM glucose, pH 7.4). The aorta was retained to a primed 21 gauge 
stainless steel cannula still remaining in cold buffer. Hearts were mounted on the Langendorff 
perfusion rig and retrogradely perfused with modified Krebs-Henseleit buffer equilibrated 
with carbogen (5 % CO2, 95 % O2) under constant perfusion pressure (60 mmHg). 
Temperature of the perfusate was adjusted to 37°C. Hearts were electrically stimulated with a 
coaxial electrode at 8.3 Hz (500 bpm). Correct position of the electrode at the sinus node was 
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assured by ECG recordings using two surface electrodes and a neutral zero electrode. To 
measure left ventricular pressure (LVP) a self-made balloon was passed through the mitral 
valve and inserted into the left ventricle. This balloon was connected to a calibrated pressure 
transducer (APT300, Hugo Sachs electronics, Germany) via a fluid filled tube. Other 
parameters were calculated based on the LVP such as maximum rate of pressure increase and 
pressure decrease (+dLVP/dtmax, −dLVP/dtmax). All data were acquired using the Isoheart 
software (Hugo Sachs Electronics, Germany). Hearts were allowed to recover for 20 min 
before measurements were performed. Only hearts with a developing pressure above 40 
mmHg were used for analysis. After baseline measurements isoproterenol (ISO) was added 
via a syringe pump at a concentration of 50 nM.  
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 Table S1. Primer pairs for real time RT-PCR are shown.  
Gene Primer sequence 
Mm_Col1a1_forward 5`-TGT AAA CAC CCC AGC GAA GAA-3` 
Mm_Col1a1_reverse 5`-CTG AGT TGC CAT TTC CTT GGA-3` 
Mm_Col3a1_forward 5`-CTC ACC CTT CTT CAT CCC ACT CTT A-3` 
Mm_Col3a1_reverse 5`-ACA TGG TTC TGG CTT CCA GAC AT-3` 
Mm_Ctgf_forward 5`-TTC CCG AGA AGG GTC AAG CT-3` 
Mm_Ctgf_reverse 5`-TTG GGT CTG GGC CAA ATG T-3` 
Mm_Hprt_forward 5`-GCT TTC CCT GGT TAA GC AGT ACA-3` 
Mm_Hprt_reverse 5`-ACA CTT CGA GAG GTC CTT TTC AC-3` 
Mm_Nppa_forward 5`-GGG GGT AGG ATT GAC AGG AT-3` 
Mm_Nppa_reverse 5`-ACA CAC CAC AAG GGC TTA GG-3` 
Mm_Nppb_forward 5`-GCA CAA GAT AGA CCG GAT CG-3` 
Mm_Nppb_reverse 5`-CTT CAA AGG TGG TCC CAG AG-3` 
Mm_MuRF1_forward 5`-CCT GCA GAG TGA CCA AGG A-3` 
Mm_MuRF1_reverse 5`-GGC GTA GAG GGT GTC AAA CT-3` 
Mm_Mapkapk2_forward 5`-CAG CAA AAA TTC GCC CTA AA-3` 
Mm_Mapkapk2_reverse 5`-AGT GCA GCT CCA CCT CTC TG-3` 
Mm_Mapkapk3_forward 5`-CTG AAT GGT TAG ATG TCT CTG AGG-3` 
Mm_Mapkapk3_reverse 5`-GCC TCT CTG TGG GAT CTG TC-3` 
Mm_Myh1_forward 5`-AAT CAA AGG TCA AGG CCT ACA A-3` 
Mm_Myh1_reverse 5`-GAA TTT GGC CAG GTT GAC AT-3` 
Mm_Myh2_forward 5`-AAC TCC AGG CAA AAG TGA AAT C-3` 
Mm_Myh2_reverse 5`-TGG ATA GAT TTG TGT TGG ATT GTT-3` 
Mm_Myh3_forward 5`-AGAGGGTTTCTCATGCGTGT-3` 
Mm_Myh3_reverse 5`-TGTTGTACTGGATGCAGAAGAT -3` 
Mm_Myh4_forward 5`-TGG CCG AGC AAG AGC TAC-3` 
Mm_Myh4_reverse 5`-TTG ATG AGG CTG GTG TTC TG-3` 
Mm_Myh6_forward 5`-GCC AAG ACT GTC CGG AAT GA-3` 
Mm_Myh6_reverse 5`-TGG AAG ATC ACC CGG GAC TT-3` 
Mm_Myh7_forward 5`-CAA AGG CAA GGC AAA GAA AG-3` 
Mm_Myh7_reverse 5`-TCA CCC CTG GAG ACT TTG TC-3` 
 
Col1a1 indicates collagen, type I, alpha 1; Col3a1, collagen, type III, alpha 1; Ctgf, 
connective tissue growth factor, Hprt, hypoxanthine-guanine phosphoribosyltransferase; 
Nppa, natriuretic peptide A; Nppb, B-type natriuretic factor; MuRF1, muscle RING-finger 1; 
Mapkapk, mitogen-activated protein kinase-activated protein kinase; Myh, myosin heavy 
chain. 
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Table S2. GO-term analysis of upregulated proteins in DKO soleus muscle. 
GO-term Biological process 
Number 
of 
proteins 
p-value 
Muscle organ development 5 2,26E-03 
Muscle tissue development 3 6,88E-02 
Myofibril assembly 2 5,84E-02 
Actomyosin structure organization 2 7,62E-02 
Proteolysis involved in cellular protein catabolic process 6 2,58E-02 
Ubiquitin-dependent protein catabolic process 3 7,32E-02 
Response to temperature stimulus 3 1,13E-02 
Response to heat 3 4,56E-03 
   
GO-term Cellular component 
Number 
of 
proteins 
p-value 
Cytoskeleton 7 7,92E-02 
Cullin-RING ubiquitin ligase complex 2 4,78E-02 
   
GO-term Molecular function 
Number 
of 
proteins 
p-value 
Ubiquitin protein ligase complex 2 4,13E-02 
AMP binding 2 5,85E-02 
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Table S3. GO-term analysis of downregulated proteins in DKO soleus muscle. 
GO-term Biological process 
Number 
of 
proteins 
p-value 
Mitochondrion organization 3 5,49E-02 
Mitochondrial transport 3 1,16E-02 
Electron transport chain 7 4,59E-06 
Cellular respiration 4 1,56E-03 
Oxidation reduction 13 7,99E-06 
Generation of precursor metabolites and energy 8 6,45E-05 
Energy derivation by oxidation of organic compounds 4 6,56E-03 
Fatty acid metabolic process 4 3,49E-03 
   
GO-term Cellular component 
Number 
of 
proteins 
p-value 
Mitochondrion 36 1,91E-17 
Mitochondrial inner membrane 16 3,30E-11 
Respiratory chain 5 3,99E-04 
Mitochondrial lumen 6 1,78E-03 
Mitochondrial matrix 6 1,78E-03 
   
GO-term Molecular function 
Number 
of 
proteins 
p-value 
Nucleoside binding 12 5,79E-02 
Nucleotide binding 16 3,33E-02 
Ribonucleotide binding 13 6,79E-02 
Adenylnucleotide binding 12 5,30E-02 
ATP binding 12 3,62E-02 
Oxidoreductase activity, acting on heme group of donors 4 1,18E-04 
Cytochrome-c oxidase activity 4 1,18E-04 
Heme-copper terminal oxidase activity 4 1,18E-04 
Methylcrotonyl-CoA carboxylase activity 2 8,41E-03 
Electron carrier activity 4 5,33E-02 
Hydrogen ion transmembrane transporter activity 4 4,96E-03 
Inorganic cation transmembrane transporter activity 4 1,63E-02 
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Supplementary Figures 
Fig. S1 
a Immunoblotting of proteins from gastrocnemius/plantaris (GP) and tibialis anterior (TA) 
from control and DKO mice using anti-MuRF2 and anti-MuRF3 antibody, as indicated, 
confirmed absence of MuRF2 and/or MuRF3 proteins in the respective single and double 
knockout mice. Actin served as loading control. b Analysis of skeletal muscle mass of 
gastrocnemius/plantaris (GP) and tibialis anterior (TA) from control (n = 30) and DKO (n = 
26) mice. Muscle weights were normalised to the tibia length. Data are shown as mean ± 
SEM. 
 
Fig. S2 
RT-PCR analysis of MuRF1 (encoded by Trim63) gene expression in soleus (Sol), extensor 
digitorum longus (EDL), gastrocnemius/plantaris (GP) and tibialis anterior (TA) from 
control (n = 8-9) and DKO (n = 4-6) mice. Hypoxanthine-guanine phosphoribosyltransferase 
(Hprt) expression was used as reference. Data are represented as mean ± SEM. 
 
Fig. S3 
a Hematoxyline & eosin stain of cross-sections from gastrocnemius/plantaris (GP) and 
longitudinal sections from tibialis anterior (TA) from control and DKO mice. 
Subsarcolemmal accumulations of eosinophilic material occurred around a central core of 
myofibres in DKO muscles (arrow). Centrally localized nuclei are present in DKO but not 
control muscle (arrowhead). Scale bar, 50 µm. b Gomori´s Trichrome stain of cross-sections 
from gastrocnemius/plantaris (GP) and longitudinal sections from tibialis anterior (TA) from 
control and DKO mice. Protein aggregates (black and white arrows) are depicted. 
 
Fig. S4 
Immunohistochemistry of cross-sections from soleus (Sol) and extensor digitorum longus 
(EDL) using anti-laminin (green) antibody. Filamentous actin was stained with phalloidin-
labeled tetramethylrhodamine (TRITC, red) and nuclei were stained with 4',6-diamidino-2-
phenylindole (DAPI; blue). Protein aggregations are indicated (arrow). Scale bar, 50 µm. 
 
Fig. S5 
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Real-time RT-PCR analysis of myosin heavy chain (Myh) -1, -2, -3, -4, and -7 expression in 
gastrocnemius/plantaris (GP) and tibialis anterior (TA) from control (n = 8) and DKO (n = 
4-6) mice. Hypoxanthine-guanine phosphoribosyltransferase (Hprt) expression was used as 
reference. Data are represented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. 
 
Fig. S6 
Maximal force development was measured in soleus (Sol) and extensor digitorum longus 
(EDL) of female control (n = 9 each) and DKO (Sol, n = 12; EDL, n = 11) mice. Specific 
force [mN/mm2] per stimulation frequency [Hz] is shown. Date are depicted as mean ± SEM. 
*p < 0.05, **p < 0.01, ***p < 0.001. 
 
Fig. S7 
a Real-time RT-PCR analysis of MuRF1 (encoded by Trim63) gene expression in hearts of 
control (n = 8) and DKO (n = 4) mice. Hprt expression was used as reference. Data are 
represented as mean ± SEM. b Real-time RT-PCR analysis of connective tissue growth factor 
(Ctgf) and collagen, type I, alpha 1 (collagen 1; Col1a1), and collagen, type III, alpha 1 
(collagen 3, Col3a1) gene expression in hearts of control (n = 8) and DKO (n = 4) mice. Hprt 
expression was used as reference. Data are represented as mean ± SEM. 
 
Fig. S8 
Heterodimerization of MuRF-family members. a Rat cardiac myoblasts (H9c2-cells) were 
transfected with expression plasmids encoding pZsGreen-N1-MuRF1, pmCherry-N1-MuRF2, 
pZsGreen-N1-MuRF2, pmCherry-N1-MuRF3 alone or in combination as indicated. 
Filamentous actin was stained with tetramethylrhodamine-labeled phalloidin (TRITC, red) 
and nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, blue). MuRF1 and 
MuRF2 were predominantly cytoplasmatic, and MuRF3 resided at microtubuli. Scale bar, 10 
µm. b COS-7-cells were transfected with expression plasmids encoding FLAG- and/or Myc-
tagged MuRF1, -2 and/or -3, as indicated. Input MuRF1, 2 and 3 proteins detected by 
immunoblot (IB) are shown. MuRF1, 2 and 3 proteins co-immunoprecipitated with their 
respective family members are shown in the bottom panel. c Mouse skeletal myoblasts 
(C2C12-cells) were transfected with expression plasmids encoding Myc-tagged MuRF1, -2 
and/or -3 for 24, 48 or 72 h, as indicated. 
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Fig. S9 
Heat-map of the Z-transformed p-values obtained by GO-analysis of proteins upregulated and 
downregulated in DKO muscle. The 30 % upregulated a and 30 % downregulated b proteins 
in DKO soleus were used for the Gene Ontology (GO) analysis with the DAVID online 
tool[3]. The obtained p-values of GO-terms cellular component α and molecular function β 
that were significantly enriched (p < 0.05) were log-transformed, Z-transformed, 
hierarchically clustered, and plotted as a heat map. Color key indicates p-values. 
 
Fig. 10 
KEGG pathway analysis of proteins involved in mitochondrial function downregulated in 
DKO muscle (oxidative phosphorylation). Proteins downregulated in DKO compared to 
control muscle are indicated (red asterisks). 
 
Fig. S11 
Peptide specific anti-MuRF2 and anti-MuRF3 antibody. Specificity of the anti-MuRF2 (top 
row) and anti-MuRF3 (bottom row) antibody from two immunizations (left and right panel 
each) was confirmed by western blot analyses using lysates from COS-7 cells transfected 
with expression plasmids encoding Myc-(His)6-tagged MuRF1, -2 or -3, as indicated.  
 
Fig. S12 
Immunoblotting of proteins from gastrocnemius/plantaris (GP), tibialis anterior (TA), soleus 
(Sol), extensor digitorum longus (EDL), left ventricle (LV), right ventricle (RV) (left panel) 
and various tissues (as indicated, right panel) from wild type mice using anti-MuRF2 or anti-
MuRF3 antibody illustrate muscle specific expression pattern of MuRF proteins. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as control. 
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